Article
Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.
Pharmacogenomics - 1 Mar 2012
Narasimhan Sneha, Lohoff Falk W
Abstract excerpt
While antidepressants are widely used to treat mood and anxiety disorders, only half of the patients will respond to antidepressant treatment and only one-third of patients experience a full remission of symptoms. The identification of genetic biomarkers that predict antidepressant-treatment response can improve current clinical practice. This is an emerging field known as pharmacogenetics, which comprises of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
